suPARnostic: an advanced predictive tool for detecting recurrence in renal cell carcinoma

BACKGROUND: Plasma soluble urokinase-type Plasminogen Activator Receptor (suPAR) predicts disease aggressiveness in renal cell carcinoma (ccRCC), but its prognostic accuracy has not been investigated. To investigate the prognostic accuracy of preoperative plasma suPAR in patients who received curati...

Descripción completa

Detalles Bibliográficos
Autores principales: Azawi, Nessn, Mosholt, Karina Sif Sondergaard, Fryd, Nathalie Demuth, Lund, Lars, Brignone, Juan Ignacio, Hvid, Nanna, Wulf-Johansson, Helle, Pedersen, Ole Birger Vesterager, Saekmose, Susanne Gjørup, Dabestani, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594785/
https://www.ncbi.nlm.nih.gov/pubmed/37875832
http://dx.doi.org/10.1186/s12894-023-01337-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594785/
https://www.ncbi.nlm.nih.gov/pubmed/37875832
http://dx.doi.org/10.1186/s12894-023-01337-z

Ejemplares similares